Kathleen Freson: Protein C Deficiency as a Genetic Modifier of Severe Haemophilia A
Kathleen Freson, Professor at KU Leuven, Chair of the International Society on Thrombosis and Haemostasis (ISTH), shared a post on LinkedIn:
“In a patient with severe Haemophilia A but unexpectedly mild bleeding, we identified a heterozygous pathogenic variant in PROC causing partial protein C deficiency, which improved thrombin generation through a natural Rebalancing Effect on haemostasis.
This work highlights how genetic modifiers can attenuate disease severity and multigene panel testing can identify such natural rebalancing mechanisms!”
Title: Prothrombotic PROC variant rebalancing haemostasis in severe haemophilia A with attenuated bleeding risk
Authors: Radha Ramanan, Quentin Van Thillo, Renaud Lavend’homme, Christine Van Laer, Chantal Thys, Koenraad De Wispelaere, Sarissa Baert, Cyrielle Kint, Peter Verhamme, Thomas Vanassche, James D. McFadyen, Andrew C. Perkins, Huyen A. Tran, Veerle Labarque, Marc Jacquemin, Kathleen Freson
Read the Full Article on Journal of Thrombosis and Haemostasis.

Other articles featuring Kathleen Freson on Hemostasis Today.
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis
-
Sep 6, 2026, 16:16Venk Murthy: 2018 vs 2026 ACC/AHA Lipid Guidelines – A Shift From RCTs to Expert Opinion?
-
Sep 6, 2026, 16:11Silmara Montalvão: Improving Global Hemophilia Diagnostics Through Sustained External Quality Assessment
-
Sep 6, 2026, 14:50Mohamed F Doheim: Unraveling the Symphony of Stroke Management
-
Sep 6, 2026, 14:47Ahmed Bennis: E-Cigarette Use and Early Cardiovascular Risk in Young Adults
-
Sep 6, 2026, 14:46William Wallace: Iron Deficiency Can be Present Before Hemoglobin Falls and Before Anemia Appears
-
Sep 6, 2026, 14:15Listening to One Another Drives Innovation and Better Therapies in Hemophilia Care – Global Hemophilia Report